BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

350 related articles for article (PubMed ID: 16428031)

  • 1. Herbal remedies for anxiety - a systematic review of controlled clinical trials.
    Ernst E
    Phytomedicine; 2006 Feb; 13(3):205-8. PubMed ID: 16428031
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.
    Sarris J; McIntyre E; Camfield DA
    CNS Drugs; 2013 Apr; 27(4):301-19. PubMed ID: 23653088
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health policy versus kava (Piper methysticum): Anxiolytic efficacy may be instrumental in restoring the reputation of a major South Pacific crop.
    Thomsen M; Schmidt M
    J Ethnopharmacol; 2021 Mar; 268():113582. PubMed ID: 33189846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of kava extract for treating anxiety: systematic review and meta-analysis.
    Pittler MH; Ernst E
    J Clin Psychopharmacol; 2000 Feb; 20(1):84-9. PubMed ID: 10653213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kava: a comprehensive review of efficacy, safety, and psychopharmacology.
    Sarris J; LaPorte E; Schweitzer I
    Aust N Z J Psychiatry; 2011 Jan; 45(1):27-35. PubMed ID: 21073405
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nutritional and herbal supplements for anxiety and anxiety-related disorders: systematic review.
    Lakhan SE; Vieira KF
    Nutr J; 2010 Oct; 9():42. PubMed ID: 20929532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Re-introduction of kava (Piper methysticum) to the EU: is there a way forward?
    Sarris J; Teschke R; Stough C; Scholey A; Schweitzer I
    Planta Med; 2011 Jan; 77(2):107-10. PubMed ID: 20814850
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the safety of kava extract in the treatment of anxiety.
    Stevinson C; Huntley A; Ernst E
    Drug Saf; 2002; 25(4):251-61. PubMed ID: 11994028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kava (Piper methysticum).
    J Soc Integr Oncol; 2009; 7(4):170-2. PubMed ID: 19883532
    [No Abstract]   [Full Text] [Related]  

  • 10. Therapeutic potential of kava in the treatment of anxiety disorders.
    Singh YN; Singh NN
    CNS Drugs; 2002; 16(11):731-43. PubMed ID: 12383029
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Kava and St. John's Wort: current evidence for use in mood and anxiety disorders.
    Sarris J; Kavanagh DJ
    J Altern Complement Med; 2009 Aug; 15(8):827-36. PubMed ID: 19614563
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kava Anxiety Depression Spectrum Study (KADSS): a mixed methods RCT using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Adams J; Bone K; Byrne G
    Complement Ther Med; 2009 Jun; 17(3):176-8. PubMed ID: 19398072
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Formulations of dietary supplements and herbal extracts for relaxation and anxiolytic action: Relarian.
    Weeks BS
    Med Sci Monit; 2009 Nov; 15(11):RA256-62. PubMed ID: 19865069
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Kava extract for treating anxiety.
    Pittler MH; Ernst E
    Cochrane Database Syst Rev; 2003; 2003(1):CD003383. PubMed ID: 12535473
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Herbal medicines in the treatment of psychiatric disorders: 10-year updated review.
    Sarris J
    Phytother Res; 2018 Jul; 32(7):1147-1162. PubMed ID: 29575228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Kava Anxiety Depression Spectrum Study (KADSS): a randomized, placebo-controlled crossover trial using an aqueous extract of Piper methysticum.
    Sarris J; Kavanagh DJ; Byrne G; Bone KM; Adams J; Deed G
    Psychopharmacology (Berl); 2009 Aug; 205(3):399-407. PubMed ID: 19430766
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.
    Sarris J; Panossian A; Schweitzer I; Stough C; Scholey A
    Eur Neuropsychopharmacol; 2011 Dec; 21(12):841-60. PubMed ID: 21601431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kava for the treatment of generalised anxiety disorder (K-GAD): study protocol for a randomised controlled trial.
    Savage KM; Stough CK; Byrne GJ; Scholey A; Bousman C; Murphy J; Macdonald P; Suo C; Hughes M; Thomas S; Teschke R; Xing C; Sarris J
    Trials; 2015 Nov; 16():493. PubMed ID: 26527536
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kava extract for treating anxiety.
    Pittler MH; Ernst E
    Cochrane Database Syst Rev; 2002; (2):CD003383. PubMed ID: 12076477
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Over-the-counter psychotropics: a review of melatonin, St John's wort, valerian, and kava-kava.
    Heiligenstein E; Guenther G
    J Am Coll Health; 1998 May; 46(6):271-6. PubMed ID: 9609974
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.